Curriculum vitae

CURRICULUM VITAE
József VITRAI
ADDRESS:
Home 1194 HUNGARY Budapest, Temesvár 41
BORN:
Budapest,
CITIZENSHIP: Hungarian
EDUCATION:

József Attila University, Szeged, Hungary Eötvös Lóránd University, Budapest, Hungary 1st Prize, University Society of Young Researchers "For Outstanding Teaching" Award from Scientific Society of Medical Students The Markusovszky Award of Orvosi Hetilap (Journal of Hungarian Medicine) CURRENT POSITIONS:
HealthMonitor Nonprofit Public Benefit Ltd. PREVIOUS POSITIONS:
Department of Psychiatry, Semmelweis Medical University, Budapest National Institute of Psychiatric and Neurology, Budapest Department of Psychiatry, Semmelweis Medical University, Budapest Department of Psychiatry, Semmelweis Medical University, Budapest Nathan S. Kline Institute for Psychiatric Research, Orangeburg, N.Y. Head of Division of Medical Statistics and Epidemiology Senior Consultant for Biostatistics and Psychiatric Epidemiology National Institute of Psychiatric and Neurology, Budapest MEDINFO, National Institute for Health Care Research and Information Project leader of National Health Interview Survey Head, Department of Health Monitoring and Epidemiology of Non–communicable Diseases National Center for Epidemiology, Budapest Secretary of the Hungarian National Group of Int. Soc. of Clin. Biostatistics Editor and statistical lector for the Psychiatria Hungarica, the journal of the Hungarian Psychiatric Association FELLOWSHIP:

Institute of Measurement and Control, Technical University, Budapest Division of Computer Research, National Institute of Neurosurgery, Budapest, Institute of Psychology of Hungarian Academy of Sciences, Budapest, Technology Assessment Tour in the USA organized by USAID Center for Disease Control and Prevention, Atlanta, USA National Center for Health Statistic, Washington, USA MEMBERSHIP

Hungarian EEG and Clinical Neurology Association Hungarian Society of Clinical Biostatistics International Society of Clinical Biostatistics J. Vitrai 1/6
RESEARCH EXPERIENCIES:

Planning and evaluation of epidemiological studies Design and evaluation of pharmacological studies Electronic recording patient data – data management Healthcare informatics – Health statistics Measurement and analysis of stochastic signals Computer techniques in EEG investigation Computer programming (assembly, Pascal, DBASE, FORTH) RESEARCH GRANT:

"Multivariate Statistical Analysis of Evoked Potentials in Pharmaco–EEG Investigation", principal investigator Semmelweis Medical University, Budapest, "Medication Refusal in Chronic Schizophrenic Patients in New York State Hospitals" "Haloperidol Blood Level and Clinical Effect" "Acute Mania: Haloperidol Dose and Lorazepam Augmentation" „The role of the social-economic health determinants in the success of the National Public Health Program” principal investigator Ministry of Health (ETT 99.) "Analysis of efficiency of alternatives to prison for drug-using offenders” principal investigator Ministry of Social Affairs and Labour (KAB-KT-M-08-0002) 2009 "Follow-up study on efficiency of alternatives to prison for drug-using offenders” principal investigator Ministry of Social Affairs and Labour (KAB-ET-09-U-0001) TEACHING:

“Physiological Basis of Electrophysiological Measurements” “Description of Stochastic Processes” “Planning and Statistical Evaluation for EEG Investigation” “Design and Evaluation of Clinical Investigation” ‘HAYNAL IMRE’ Postgraduate Medical University, Budapest “Introduction to Medical Statistics” Series of lectures to medical professionals National Institute of Psychiatry and Neurology Public Health post gradual courses, Univ. Debrecen School of Public Health “Health Status of the World population and in Hungary” Health Insurance post gradual courses, Univ. Semmelweis PUBLICATIONS:
1. Czobor,P, Vitrai,J, Bucsy,Gy: An outline of complex electrophysiological laboratory. Kórház és Röntgentechnika, 1980, 2:40–46. {in 2. Marosfi,S, Czobor,P, Vitrai,J, Tóth,I: The significance of electrophysiological methods in the diagnosis of sclerosis multiplex. In:
Juhász P.(Ed.) Sclerosis Multiplex, Akademic Press, Budapest, 1980, pp.114–134. {in Hungarian} 3. Vitrai,J, Czobor,P, Marosfi,S, L'Auné,Gy: A study of periodicity and structure of EEG complexes in a case of SSPE.
Electroenceph. Clin. Neurophysiol., 1980, 50:111–118. 4. Vitrai,J, Czobor,P, Marosfi,S, Nagypál,T, Rácz,J: Simple computer method for the recognition of epileptic spike activity.
Ideggyógyászati Szemle, 1981, 34:515–526. {in Hungarian} 5. Ungvári,G, Bitter,I, Czobor,P, Vitrai,J, Pethö,B: Zur rolle der neuroleptischen Hochdosis–Therapie und des Elektroschocks bei der
Behandlung der akuten Phase von Schizophrenien. Psychiat. Neurol. med. Psychol., Leipzig, 1981, 33:458–463. 6. Czobor,P, Vitrai,J, Simon,G, Ivanyos,G, Varga,L, Marosfi,S: Comparison of different principal component analysis models on EP
data. In: I. Györi and B. Kanyár (Eds.) Computer and Cybernetic Methods in Medicine, Academic Press, Budapest, 1982. pp.273–277. {in Hungarian} J. Vitrai 2/6
7. Vitrai,J, Czobor,P, Simon,G, Varga,L, Marosfi,S: Canonical component analysis: a method for data reduction and classification of
EPs. In: I. Györi and B. Kanyár (Eds.) Computer and Cybernetic Methods in Medicine, Academic Press, Budapest, 1982. pp.278–287. {in Hungarian} 8. Follmann,P, Kerényi,Ĺ, Vitrai,J, Czobor,P, Marosfi,S: Assessment of optic nerve function by visual evoked potential recordings in
the diagnosis of glaucoma. In: Doc. Ophtal. Proc. Series, (Eds.) J. R. Heckenlively, G. H. M. van Lith and T. Lawwil, Dr.W. Junk Publishers, Dordrecht/Boston/Lancester, 1984, pp.40:265–271. 9. Vitrai,J, Czobor,P, Simon,G, Varga,L, Marosfi,S: Beyond principal component analysis: canonical component analysis for data
reduction in classification of EPs. International Journal of Bio–Medical Computing, 1984, 15:93–111. 10. Gierow,W, Cammann,R, Vitrai,J, Czobor,P: Statistische Analysen visuell evozierter Potentiale bei frühkindlich hierngeschädigten
Kindern und einer Kontrollgruppe. Z. Psychol. 1985, 193:339–345. 11. Czobor, P., Vitrai, J.: Classification of evoked potentials with equal average. Neuroscience, 1987, 22(Suppl):S52.
12. Magyar,I, Rajna,P, Czobor,P, Vitrai,J: Importance of EEG in psychiatric diagnosis. Orvosképzés, 1987, 62:435–448. {in
13. Rajna,P, Veres,J, Vitrai,J: The place of the phenitoin (Diphedan) therapy in the antiepileptic regime. Gyógyszereink, 1990,
14. Rajna,P, Vitrai,J Szegedi,N: Is the spectral EEG analysis an appropriate method to classify the dementias? Clin Neuosci/Ideggy
Szle, 1992, 45 (1–2):23–30. {in Hungarian} 15. Vitrai,J, Czobor,P: Portrait of Michael Kohn, Tudomány (Hungarian edition of Scientific American), 1992, Nov., 77–79. {in
16. Czobor,P, Vitrai,J: Frequent mistakes in evaluation and publication of investigation in psychiatry. Psychiatria Hungarica, 1993,
17. Czobor,P, Vitrai,J: Statistical guidelines for Psychiatria Hungarica. Psychiatria Hungarica, 1993, 8:15–22. {in Hungarian}
18. Ladds,B, Convit,A, Zito,JM, Vitrai,J: Medication of patients who are incompetent to stand trial: a descriptive study of the New York
experience with judicial review. Bulletin of American Academy of Psychiatry and the Law. 1993:21:529–545. 19. Ladds,B, Convit,A, Zito,JM, Vitrai,J: The disposition of criminal charges after involuntary medication to restore competency to
stand trial. Journal of Forensic Sciences.1993,38:1142–1459. 20. Vitrai,J, Czobor,P: Methodological letter: Regression toward the mean. Why is it true that the children of bright parents are less
clever than their parents? Psychiatria Hungarica, 1993,8: 119–24. {in Hungarian} 21. Volavka,J, Zito,JM, Vitrai,J, Czobor,P: Clozapine effects on hostility and aggression in schizophrenia. Journal of Clinical
Psychopharmacology 1993,13: 287–289. 22. Zito, JM, Vitrai, J: Toward a therapeutic jurisprudence analysis of medication refusal in the court review model. Behavioral
Sciences and the Law 1993,11: 151–163. 23. Zito, JM, Volavka,J, Craig, TJ, Czobor, P, Banks, S, Vitrai, J: Pharmacoepidemiology of clozapine in 202 inpatients with
schizophrenia. Annals of Pharmacotherapy 1993,27: 1262–1269. 24. Vitrai, J, Czobor,P: Sample size in clinical investigation. Psychiatria Hungarica. 1994,9:197–202. {in Hungarian}
25. Vitrai,J, Bitter,I, Czobor,P: Placebo: the key to the medical science. Introductory thoughts to the Placebo Conference of the
Hungarian College of Neuropsychopharmacology. Psychiatria Hungarica. 1994, 9:287–290. {in Hungarian} 26. Vitrai,J, Bitter,I, Czobor,P: Placebo: Placebo: the touchstone of the medical science. Interdisciplinary review. Gyógyszereink.
27. Volavka, J, Mohammad,Y, Vitrai, J, Connolly,M, Stefanovic,M, Ford,M: Characteristics of state hospital patients arrested for
offenses committed during hospitalization. Psychiatric Services. 1995,46:796–800. 28. Agárdi T, Bartkó Gy, Vitrai J: Graphometric analysis of depressive patients. Psychiatria Hungarica, 1996;11:167–177. {in 29. Barcs,G, Vitrai, J, Halász,P: Multifactorial approach of short term memory function in two diagnostic groups in epilepsy. Clin
Neuosci/Ideggy Szle. 1996;49:96–103. {in Hungarian} 30. Chou, JC, Zito, JM, Vitrai, J, Craig,TJ, Allingham,BH, Czobor,P: Neuroleptics in acute mania: a pharmacoepidemiologic study. Ann
Pharmacotherapy 1996;30:1396–8. 31. Vitrai, J, Czobor, P: A study of the statistical level of articles in Orvosi Hetilap. 1996;137:465–472. {in Hungarian}
32. Vitrai, J: Comparison of tests. Psychatria Hungarica. 1996;11:137–146. {in Hungarian}
33. Zito, JM, Vitrai, J, Craig, TJ: Toward a therapeutic jurisprudence analysis of medication refusal in the court review model. In:
Wexler DB, Winick BJ editors. Law in a Therapeutic Key. Durham, North Carolina: Carolina Academic Press, 1996; 935–948. 34. Agárdi T, Bartkó Gy, Vitrai J, Simon L: Analysis of handwriting of schizophrenic patients. Psychiatria Hungarica, 1997;12:603–610.
35. Barcs G, Vitrai J, Halász P.: Investigation of vehicle driving ability in two diagnostic groups of epileptic patients with special
neurophysiological approach. Med Law 1997;16:277–287.
36. Tariska P, Klein V, Pánczél G, Vitrai J, Knolmayer J, Mészáros Á, Urbanics K, Kiss É.: Vascular disease risk factors and findings
in patients with Alzheimer's disease. Archives of Gerontology and Geriatrics 1997;237–243. 37. Vizi J, Arató M, Vitrai J, Somogyi A.: Clinical trial of Floxet (EGIS) vs. reference fluoxetin capsule in depression. (preliminary
results) [in Hungarian]. Háziorvos Továbbképző Szemle 1997;2:187–190.
J. Vitrai 3/6
38. Balázs J.,Bitter I.,Hideg K.,Vitrai J.: Adapting the M.I.N.I. and the M.I.N.I. PLUS questionnaires to Hungarian. Psychiatria
Hungarica, 1998;13:160–168. {in Hungarian} 39. Carpenter WT, Zito JM, Vitrai J, Volavka J.: Hypothesis testing: Is clozapine's superior efficacy dependent on moderate D2
receptor occupancy? Biol Psychiatry 1998;43:79–83.
40. Janka Z, Lux E, Vitrai J. Sexual dysfunction in patients with mood disorder treated with antidepressants in the population. Psych
Hung 13:5–17, 1988. {in Hungarian} 41. Szádóczky E., Papp Zs., Vitrai J., Ríhmer Z., Füredi J. The prevalence of major depressive and bipolar disorders in Hungary.
Results from a national epidemiologic survey. Journal of Affective Disorders 50:153–162, 1998. 42. Vitrai J., Vizi J.: Psychiatric epidemiology. In: Hungarian Textbook of Psychiatry, (eds) J. Füredy, B. Buda, A. Németh, P. Tariska.
Medicina, Budapest 1998, pp 53–72. {in Hungarian} 43. Vitrai J., Bitter I.: Methodology of psychiatric research. In: Hungarian Textbook of Psychiatry, (eds), J. Füredi, B. Buda, A. Németh,
P. Tariska. Medicina, Budapest 1998, 753–768 {in Hungarian}. 44. Vitrai J., Bitter I.: Methodology of psychiatric research. In: Hungarian Textbook of Psychiatry, (eds), J. Füredi, B. Buda, A. Németh,
P. Tariska. 2nd and 3rd Edition, Medicina, Budapest 2001, 2003, 909–918 {in Hungarian}. 45. Janszky J Halász P. Vitrai J, Rásonyi Gy, Barsi P. Hippocampal damage and the onset of epilepsy [letter]. Neurology 52 (8):1718–
46. Vokó Z., Vitrai J., Ursicz G., Lépes P. Health monitoring in Hungary in the 21st century. Népegészségügy 1:28–33, 1999. {in
47. Aszalós Zs, Barsi P, Vitrai J, Nagy Z. The significance of leukoaraiosis in vascular brain diseases. Clin Neurosci/Ideggy Szle 2000;
48. Bitter I, Hoffer G, Vitrai J, Porkoláb L, Alföldi P, Hungarian Cost Explorer Group. Cost–effectiveness of Haloperidol and Olanzapin
analysed by Markov–model in Hungary. Psychiat Hung 2000;15:18–30. {in Hungarian} 49. Szádóczky E, Papp Zs, Vitrai J, Füredi J. Anxiety and mood disorders in Hungarian adult population. Orvosi Hetilap 2000;141:17–
50. Szádóczky E, Rihmer Z, Papp Zs, Vitrai J, Füredi J. Suicide behavior in Hungarian adult population surveyed with structured
questionnaire. Psychiat Hung 2000;15:127–133. {in Hungarian} 51. Szádóczky E, Vitrai J, Rihmer Z, Füredi J. Suicide attempts in the Hungarian adult population. Their relation with DIS/DSM–III–R
affective and anxiety disorders. Eur Psychiatry 2000;15:343–7. 52. Vizi J, Vitrai J, Hoffer G. Cost–effectiveness of Risperidon and Olanzapin in schizophrenia. Tényeken Alapuló Orvoslás
53. Zsombók T, Berghammer R, Vitrai J. The role of combined physical treatment in patients with primary chronic headache.
Sportorvosi szemle 2000;4: 245–251. {in Hungarian} 54. Horvát–Karajz K, Karoliny A, Vitrai J, Sréter L, Németh J. Associations between early diagnosis of breast cancer and mortality, motivation and health promotion. Egészségnevelés. 2000; 41:10–12. {in Hungarian} 55. Boros J, Grajczjar I, Széles Gy, Vitrai J, Vizi J, Vokó Z. Preliminary Report of the National Health Interview Survey 2000. Health Promotion Research Institute, Budapest 2001. 56. Boros J, Grajczjar I, Széles Gy, Vitrai J, Vizi J, Vokó Z. Report of the National Health Interview Survey 2000: Basic estimates on health status, health behavior and health care utilization. National Center for Epidemiology, Budapest 2001. 57. Aszalós Zs, Barsi P, Vitrai J, Nagy Z. Determinants of early death by stroke and recurrent stroke. Orvosi Hetilap 2001;142:715–
58. Jekkel É, Tringer L, Vitrai J. Dysfunctional attitudes behind of suicide. Mentálhigiéné és Pszichoszomatika. 2001;3:30–34.{in
59. Osváth P, Fekete S, Vitrai J. Frequency of sexual dysfunction among patients treated with antidepressants – First results of a
multicenter, retrospective study. Psychiat Hung 2001;16:621–631. {in Hungarian} 60. Osváth P, Fekete S, Vörös V, Tényi T, Vitrai J. Sexual dysfunction among patients treated with antidepressants – A Hungarian
retrospective study. Eur Neuropsychopharm 2001;11(Suppl3):233–234. 61. Péterfai É, Pálfi S, Vitrai J, Centres of BRLP–42 study, Kurucz I, Korányi L. New treatment for diabetic nephropathy. Study on co–
inductor BRLP–42 (bimoclomol), a heath shock protein. A six months, double blind, random phase II/a clinical trial. Diabet Hung 2001;9:81–84. {in Hungarian} 62. Boros J, Grajczjar I, Németh R, Országh S, Széles Gy, Vitrai J, Vizi J, Vokó Z: Summary Report of Hungarian Health Survey 2000. National Center for Epidemiology, Budapest 2001. {in Hungarian} 63. Aszalós Z, Barsi P, Vitrai J, Nagy Z. Hypertension and clusters of risk factors in different stroke subtypes (an analysis of
Hungarian patients via Budapest Stroke Data Bank). J Hum Hypertens 2002;16(7):495–500. 64. Szűcs A, Vitrai J, Janszky J, Migléczi Gy, Halász P, Nagy Z. Sleep apnoea in acute ischaemic stroke. Agyérbetegségek.
65. Jekkel É, Tringer L, Vitrai J. Dysfunctional attitudes and suicide. Psychiatria Hungarica. 2002;17:287–297.
66. Szűcs A, Vitrai J, Janszky J, Migleczi G, Bodizs R, Halász P. Pathological sleep apnoea frequency remains permanent in
ischaemic stroke and it is transient in haemorrhagic stroke. Eur Neurol 2002; 47: 15–9. 67. Osváth P, Fekete S, Vitrai J. Problems of recognition and treatment of sexual dysfunction among patients treated with
antidepressants – a Hungarian multicenter, retrospective study. Neuropszichopharm Hung 2002; IV/2: 99–104. {in Hungarian} J. Vitrai 4/6
68. Vitrai J, Vokó Z. Health monitoring, health survey. Orvostovábbképző Szemle 2002;7:12–17. {in Hungarian}
69. Vitrai J, Vokó Z. An up to date health model. Családorvosi Fórum 2002;10:39–41. {in Hungarian}
70. Szádóczky E, Rihmer Z, Papp Zs, Vitrai J, Füredi J. Gender differences in major depressive disorder in a Hungarian community
survey. Int J Psychiat Clin 2002;6:31–37. 71. Bartkó Gy, Kanka A, Vitrai J, Vizi J, Fehér L, Pungor K: Hungarian Costs of Antipsychotic Treatments Working Group:
Comparative study on cost–effectiveness of haloperidol and risperidon using Markov–models in Hungary Psychiat Hung, 2002; 17: 499–520. 72. Aszalos Z, Barsi P, Vitrai J, Nagy Z. Lateralization as a factor in the prognosis of middle cerebral artery territorial infarct. Eur
73. Zsombok T, , Juhász G, Budavári Á, Vitrai J, Bagdy Gy. Effect of autogenic training on drug consumption in patients with primary
headache: an 8–month follow–up study. Headache 2003;43:251–257. 74. Borsos K, Vitrai J, Boros J, Németh R, Vizi J, Országh S. Health care expenditure in adult population based on national health
interview survey in 2000. Egészségügyi Gazdasági Szemle 2003; 41:25–33. {in Hungarian} 75. Osváth P, Fekete S, Vörös V, Vitrai J. Sexual dysfunction among patients treated with antidepressants—a Hungarian
retrospective study. European Psychiatry 2003; 18:412–4. 76. Juhász G, Zsombok T, Módos EA, Olajos S, Jakab B, Németh J, Szolcsányi J, Vitrai J, Bagdy Gy. NO–induced migraine attack:
strong increase in plasma calcitonin gene–related pepticide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 2003; 106: 461–70. 77. Bakacs M, Vitrai J: National public health updates 2003. National Center for Epidemiology, Budapest 2003.
78. Boros J, Csizmadia P, Hermann D, Kéki Zs, Kiss G, Németh R, Országh S, Vitrai J, Vizi J, Zakariás I: Summary Report of
Hungarian Health Interview Survey 2003. National Center for Epidemiology, Budapest 2004. 79. Vitrai J: Summary Report on World Health. National Center for Epidemiology, Budapest 2004. {in Hungarian}
80. Bakacs M, Vitrai J (eds.): Public Health Report 2004. National Center for Epidemiology 2004. {in Hungarian}
81. Vitrai J (eds.): How do investments in health system contribute to a country’s competitiveness? Ministry of Health, Budapest 2004.
82. Vitrai J, Bakacs M, Hermann D, Kabos S, Németh R: Forecasting of Health Care Demand until 2021. National Center for
Epidemiology, Budapest 2004. {in Hungarian} 83. Vitrai J, Kaposvari Cs, Bakacs M, Kiss B, Vizi J: The Hungarian Health Information System. WHO/EURO Copenhagen 2004.
84. Vitrai J (eds.): Development of the Hungarian Health System. Green Book. Ministry of Health, Budapest 2005. {in Hungarian}
85. Rodler I, Bíró L, Greiner E, Zajkás G, Szórád I, Varga A, Domonkos A, Ágoston H, Balázs A, Mozsáry E, Vitrai J, Hermann D,
Boros J, Németh R, Kéki Zs. Nutrition survey in Hungary 2003–2004. Orvosi Hetilap. 2005;146:1781–1789. {in Hungarian} 86. Zsombók T, Juhász G, Gonda X, Vitrai J, Bagdy Gy. Autogenic training modified with cognitive and symbolic elements in primary
headache. Psychiatria Hungarica. 2005;20:25–34. {in Hungarian} 87. Rodler I, Bíró L, Greiner E, Zajkás G, Szórád I, Varga A, Domonkos A, Ágoston H, Balázs A, Mozsáry E, Vitrai J, Hermann D,
Boros J, Németh R, Kéki Zs. Hungarian Nutrition Survey, 2003–2004. Orvosi Hetilap. 2005;146:1781–1789. {in Hungarian} 88. Vitrai J, Mihalicza P: Health status. In:T Kolosi T, IGy Tóth, Gy Vukovich (eds.) Social Report 2006. TÁRKI, Budapest 2006. {in
89. Vitrai J, Hermann D, Vizi J, Csaba I. How much is the real Hungarian public spending on medicines? IME 2006;5:5–10. {in
90. Biró L, Zajkás G, Greiner E, Szórád I, Varga A, Domonkos A, Ágoston H, Balázs A, Mozsáry E, Vitrai J, Hermann D, Boros J,
Németh R, Kéki Zs, Martos É. Hungarian Nutrition Survey, 2003–2004. Micronutrients: Dietary minerals. Orvosi Hetilap 2007;148: 703–708. {in Hungarian} 91. Deckovic–Vukres V, Hrkal J, Németh R, Vitrai J, Zach H. Inequalities in Health System Responsiveness. Joint World Health
Survey Report Based on Data from Selected Central European Countries. Ed.: Vitrai J. WHO/EURO Copenhagen 2007. 92. Vitrai J. How does the Hungarian population evaluate responsiveness? Executive summary of the Joint Report on responsiveness
in Croatia, the Czech Republic, Hungary, Slovenia, and Slovakia compiled for the WHO. TÁRKI Budapest 2007. {in Hungarian} 93. Zajkás G, Biró L, Greiner E, Szórád I, Ágoston H, Balázs A, Vitrai J, Hermann D, Boros J, Németh R, Kéki Zs, Martos É.
Hungarian Nutrition Survey, 2003–2004. Micronutrients: vitamins. Orvosi Hetilap 2007;148: 1593–1600. {in Hungarian} 94. Vitrai J: Estimated societal cost of Hungarian influenza epidemic in season 2007/8. HealthMonitor, Budapest, 2008. {in Hungarian}
95. Bakacs M, Vitrai J. How do social-economic differences in residential characteristics affect mortality? A literature review. Orvosi
Hetilap 2008;28:1317-1321. {in Hungarian} 96. Vitrai J. The Hungarian health system is like in the USA? According to the OECD, it wastes but does not lavish. Informatika és
Menedzsment az Egészségügyben. 2008;8:5-7. {in Hungarian} 97. Bakacs M, Vitrai J, Várhalmi Z, Kaposvári Cs, Herrman D, Kabos S, Lőw A: Analysis of associations between mortality and
biological and social-economic individual determinants. Orvosi Hetilap 2008. 50: 2371–2376. {in Hungarian} 98. Vitrai J, Hermann D, Kaposvári Cs, Németh R: Health Interview Survey in Hódmezővásárhely, HODEF2008. HealthMonitor,
99. Vitrai J, Hermann D, Kabos S, Kaposvári Cs, Lőw A, Páthy Á, Várhalmi Z: Health Inequalities in Hungary. Data for estimation of
geographical inequalities in health care needs. HealthMonitor, Budapest, 2008. {in Hungarian} J. Vitrai 5/6
100. Vitrai J, Füzesi Zs, Kaposvári Cs, Kapócs G, Rácz J, Sinkó E: Here, in Hungary you must die? Lege Artis Med 2009;19:462–
101. Vitrai J, Bakacs M, Kaposvári Cs, Németh R. Need adjusted inequalities in use of health care in Hungary. HealthMonitor,
102. Vitrai J, Busa Cs, Füzesi Zs, Busa Cs, Szilágyi J: Evaluation of the “•National Strategy to Combat the Drug Problem” based on
structured interviews and document analysis. . HealthMonitor, Budapest, 2009. {in Hungarian} 103. Vitrai J, Tistyán L: Summary on screening the “Alcohol Strategy and Policy 2009” for health impact analysis. HealthMonitor,
104. Vitrai J, Busa Cs, Füzesi Zs, Kesztyüs M, Szilágyi J, Tistyán L: Results of the "Analysis of efficiency of alternatives to prison
targeting drug-using offenders”. HealthMonitor, Budapest, 2009. {in Hungarian} 105. Vitrai J, Füzesi Zs, Kaposvári Cs, Kapócs G, Rácz J, Sinkó E: “Should I explain this to you?” Reply to Éva Bondár. Lege Artis
Med 2010;20:65–68. {in Hungarian} 106. Vitrai J, Bakacs M, Juhász A, Kaposvári Cs, Nagy Cs: “Report from a country left behind …” Health Report 2010. HealthMonitor,
107. Vitrai J, Bakacs M, Juhász A, Kaposvári Cs, Nagy Cs: “Report from a country left behind …” Health Report –2010 – Summary.
Lege Artis Med 2010;20:217–221. {in Hungarian} 108. Vitrai J. (ed.): Despite of punishment. Evaluation of quasi-coercive treatment of offenders in Hungary. L’Harmattan, Budapest
109. Vitrai J, Bakacs M, Kaposvári Cs, Németh R: Need adjusted inequalities in use of health care in Hungary. Lege Artis Med
110. Vitrai J. Equity, patients’ equality, equal access to health services and therapies. In: Bodrogi J (ed.) The Hungarian Health
System. Socio-economic considerations and sectoral opinion map. Semmelweis Publisher, Budapest 2010. 111. Vitrai J. The sick man of Europe? Public Service Review: Science and Technology. 2010;8:220-221.
112. Vitrai J. Kiss N, Kriston Vízi G. Review and critical evaluation of the Hungarian health service planning. HealthMonitor,
113. Uzzoli A, Bakacs M, Gémes K, Kiss N, Kövi R, Vitrai J. Geographical inequality of health care in Hungary. Comitatus.
J. Vitrai 6/6

Source: http://www.egeszsegmonitor.hu/dok/CVVitrai_en.pdf